Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...

Novartis AG agreed to buy Avidity Biosciences Inc. in a $12 billion deal that’s the Swiss drugmaker’s biggest acquisition in ...

Biotechnology's rapid development of the future of medicine shows little sign of slowing down. We speak to the International ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...

Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...

The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

Titian Life Sciences is pursuing a multimodal approach to precision medicine and healthy ageing, integrating biotechnology, ...

Alps ordinary shares to list on the Nasdaq under the symbol “ALPS” onKUALA LUMPUR, Malaysia and NEWARK, Del., Oct. 31, 2025 ...

(Oct 27): Novartis AG agreed to buy biotechnology company Avidity Biosciences Inc in a deal valued at US$12 billion, making ...

The bears will point out that Novo Nordisk is losing ground in the GLP-1 market to its most important competitor, Eli Lilly.